Back to search
FDAFDA · Food and drugs·Recall number D-0616-2026

Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30

Published July 1, 2026 · Recall initiated: June 4, 2026

Summary

FDA records drug Class II recall D-0616-2026, published July 1, 2026 and initiated June 4, 2026. Recalling firm: Amgen, Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: 1157056, Exp. Date 02/29/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if SENSIPAR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SENSIPAR
Manufacturer
Amgen, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 1157056, Exp. Date 02/29/2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30 recalled?

Yes. FDA published recall D-0616-2026 on July 1, 2026. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SENSIPAR.